Confluent and reticulate papillomatosis (syn. Gougerot-Carteaud syndrome)

LAST UPDATED: Aug 03, 2021

Introduction

Confluent and reticulated papillomatosis is a rare condition, usually affecting teenagers and young adults, characterised by grey-brown scales on the upper trunk that become confluent.

This chapter is set out as follows:


Aetiology

  • Although the cause in unknown there is evidence to suggest an infective aetiology 

History

  • The condition is most commonly seen around puberty
  • Patients are usually asymptomatic 

Clinical findings

Distribution

  • ​Lesions usually arise on the central chest and the midline of the back, and then gradually spread to affect other areas of the trunk, as well as the neck and axillae
  • Other sites are occasionally affected 

Morphology

  • Lesions are small, grey-brown, and scaly, and over time coalesce to form larger patches with a net-like pattern at the peripheries

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • First-line treatment - lymecycline 408 mg OD (or doxycycline 100 mg OD) for 6-8 weeks
  • Several other antibiotics, especially minocycline and azithromycin, have also been found to be effective - minocycline has occasionally been associated with hyperpigmentation, hepatotoxicty, and lupus; and should be avoided if possible
  • Discontinuation of treatment may result in recurrence

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco